T4	Treatment 80 87	dapsone
T5	Subject 0 61	A 35-year-old female with borderline lepromatous (BL) leprosy
T6	Effect 96 108	erythroderma
T7	Age 2 13	35-year-old
T8	Gender 14 20	female
T9	Treat-Disorder 26 61	borderline lepromatous (BL) leprosy
T10	Drug 80 87	dapsone
T3	Adverse_event 88 95	induced
E1	Adverse_event:T3 
